Tag Archives: Drug addiction

'Drug prevention and information' programme

‘Drug prevention and information’ programme

Outline of the Community (European Union) legislation about ‘Drug prevention and information’ programme

Topics

These categories group together and put in context the legislative and non-legislative initiatives which deal with the same topic.

Justice freedom and security > Combating drugs

‘Drug prevention and information’ programme (2007-2013)

Document or Iniciative

Decision 1150/2007/EC of the European Parliament and of the Council of 25 September establishing for the period 2007-2013 the specific programme ‘Drug prevention and information’ as part of the General Programme ‘Fundamental Rights and Justice’.

Summary

The death rate from drug addiction in Europe is very high. It is essential to measure the immediate and long-term consequences of drug use on health and social and psychological development, and the equality of the chances of the individuals concerned.

The ‘Drug prevention and information’ programme set up by the European Union has three objectives. Specifically to:

  • prevent and reduce drug use, drug addiction and the associated inherent risks;
  • improve information about drug use;
  • support the implementation of the EU Drugs Strategy.

To this end, the programme supports transnational actions aimed at:

  • creating multi-disciplinary networks;
  • ensuring the expansion of the knowledge base, as well as the exchange of information and good practices;
  • raising awareness of the health and social problems caused by drug use;
  • preventing drug use.

Scope

The actions financed by this programme are:

  • the actions implemented by the Commission (research, surveys, conferences, campaigns, public events, analysis, Internet sites, etc.);
  • transnational projects of European interest presented by Member States or by candidate countries for membership of the EU;
  • the activities of non-governmental organisations and other bodies pursuing aims of general European interest.

The actions developed under this programme are open to public or private bodies, active in terms of preventing, or providing information, on drug use.

The programme is targeted at all groups implicated in drug use, but most particularly at ‘at risk groups’ such as young people, women, vulnerable groups and people living in socially disadvantaged areas.

Other targeted groups include educational staff, parents, teachers, social workers, local and national authorities, medical and paramedical personnel, judicial staff, law enforcement and penitentiary authorities, non-governmental organisations, trade unions and religious communities.

Financing

The programme has a budget for 2007-2013 of EUR 21.35 million. Grants are awarded by the Commission following calls for proposals, taking into account:

  • the conformity of the proposed action with the annual work programme;
  • the consistency of the expected results with the programme objectives;
  • the sum asked for and whether it is appropriate to the expected results;
  • the geographical and social impact of the action and its likely effect on the public;
  • citizen involvement in the organisation of the bodies concerned.

Context

The EU has launched a number of initiatives in its fight against drugs. In addition to the EU Drugs Strategy for the period 2005-2012, an Action Plan was adopted in order to translate the strategy into concrete actions.

The ‘Drug prevention and information’ programme forms part of the general programme ‘Fundamental Rights and Justice’ 2007-2013 aimed at promoting freedom, security and justice in the EU. The latter also includes the Criminal Justice, Civil Justice, and Fundamental Rights and Citizenship specific programmes, and the Daphne III programme on combating violence.

References

Act Entry into force Deadline for transposition in the Member States Official Journal

Decision 1150/2007/EC

23.10.2007

OJ L 257, 3.10.2007

Related Acts

Report on the interim evaluation of the specific Programme ‘Drug prevention and information’ for the period 2007-2013 [COM(2011) 246 final – Not published in the Official Journal].

The evaluation of the programme shows that it has recorded good results during the first three years of implementation and that several objectives have been achieved. The Commission regrets, however, the insufficient budget it has at its disposal and which prevents the programme from having a real effect at European level. It therefore proposes to increase the financial resources of the programme, and also to prioritise projects with a European dimension, to simplify the administrative procedures and to improve the dissemination of the results obtained.

This summary is for information only. It is not designed to interpret or replace the reference document, which remains the only binding legal text.

Prevention and reduction of risks associated with drug dependence

Prevention and reduction of risks associated with drug dependence

Outline of the Community (European Union) legislation about Prevention and reduction of risks associated with drug dependence

Topics

These categories group together and put in context the legislative and non-legislative initiatives which deal with the same topic.

Justice freedom and security > Combating drugs

Prevention and reduction of risks associated with drug dependence

Document or Iniciative

Council Recommendation 2003/488/EC of 18 June 2003 on the prevention and reduction of health-related harm associated with drug dependence [Official Journal L 165 of 3.07.2003].

Summary

This Recommendation encourages Member States to set as a public health objective the prevention of drug dependence and the reduction of related risks. It also envisages the following measures to reduce substantially the incidence of drug-related health damage (such as HIV, hepatitis B and C and tuberculosis) and the number of drug-related deaths:

  • information and counselling for drug users, their families and the public;
  • methods based on outreach work (local level, contact with specific target groups) as part of national drug policies;
  • encouraging the involvement of peers and volunteers in outreach work;
  • promoting professional networking;
  • providing comprehensive substitution treatment (adequate psychosocial care, detoxification);
  • preventing diversion of substitution substances;
  • access for drug abusers in prison to services similar to those provided to drug abusers not in prison, in a way that does not compromise the continuous and overall efforts to keep drugs out of prison;
  • promoting vaccination against hepatitis B and prophylactic measures against HIV, hepatitis B and C, tuberculosis and sexually transmitted diseases, as well as screening for all these diseases;
  • provision of appropriate access to the distribution of condoms, needles and syringes and to exchange centres;
  • provision of emergency services to deal with overdoses;
  • organisation of appropriate integration between primary health care (including mental health care) and social care and specialised approaches in risk reduction;
  • support for training and accreditation for risk reduction professionals.

The Recommendation also proposes the development of appropriate evaluation based on:

  • using scientific evidence of effectiveness as the main basis for selecting the type of intervention;
  • the inclusion of needs assessments at the initial stage of any programme;
  • developing and implementing adequate evaluation protocols for all programmes;
  • establishing and implementing quality evaluation criteria, taking into account the Recommendations of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA);
  • organising data collection and information dissemination according to the EMCDDA recommendations through the REITOX national focal points;
  • the use of evaluation results to develop more effective policies;
  • setting up evaluation training programmes;
  • introducing innovative methods involving all actors and stakeholders;
  • encouraging the exchange of skills, experience, programme results, etc. within the European Union and with the candidate countries.

The Council asks the Member States to report to the Commission on the implementation of this Recommendation within two years of its adoption.
It calls on the Commission to cooperate with the relevant international organisations (World Health Organisation, United Nations International Drug Control Programme, Pompidou Group, Council of Europe) in line with the EU Action Plan on Drugs (2000-2004), and to prepare a report, with the technical support of the EMCDDA, with a view to revising and updating this Recommendation.

Background

Endorsed by the Helsinki European Council in December 19999, the European Union Drugs Strategy (2000-2004) included three main targets:

  • to reduce significantly over five years the prevalence of drug use, as well as new recruitment to it;
  • to reduce substantially over five years the incidence of drug-related health damage (HIV, hepatitis, tuberculosis) and the number of drug-related deaths;
  • to increase substantially the number of successfully treated addicts.

The EU Drugs Strategy gave rise to the EU Action Plan on Drugs (2000-2004), implemented in May 1999, one of the aims of which was to strengthen cooperation at national and European levels. The parallel Community Framework for Action in the field of Public Health (2003-2008), adopted in September 2002, includes the development of strategies to implement measures in this field.

The present resolution was adopted as part of the follow-up to these various texts and to contribute to achieving the targets of the EU Drugs Strategy.

Related Acts

[Official Journal C 168 of 8.7.05].

Communication from the Commission to the Council and the European Parliament of 22 October 2004 on the results of the final evaluation of the EU Drugs Strategy and Action Plan on Drugs (2000-2004) [COM(2004) 707 final – Not published in the Official Journal].

Communication from the Commission to the Council and the European Parliament of 4 November 2002 on the mid-term evaluation of the EU Action Plan on Drugs (2000-2004) [COM(2002) 599 final – Not published in the Official Journal].

Decision No 1786/2002/EC of the European Parliament and of the Council of 23 September 2002 adopting a programme of Community action in the field of public health (2003-2008) [Official Journal L 271 of 09.10.2002].

European Union Drugs Strategy (2000-2004) of 1 December 1999 [Council document 12555/3/99 – Not published in the Official Journal].

Communication from the Commission to the Council, the European Parliament, the Economic and Social Committee and the Committee of the Regions of 26 May 1999 on the European Union action plan to combat drugs (2000-2004) [COM(1999) 239 final – Not published in the Official Journal].

Decision No 102/97/EC of the European Parliament and of the Council of 16 December 1996 adopting a programme of Community action on the prevention of drug dependence within the framework for action in the field of public health (1996-2000) [Official Journal L 19 of 22.01.1997].

The EU drugs action plan

The EU drugs action plan

Outline of the Community (European Union) legislation about The EU drugs action plan

Topics

These categories group together and put in context the legislative and non-legislative initiatives which deal with the same topic.

Justice freedom and security > Combating drugs

The EU drugs action plan (2005-08)

In order to counter the drugs problem from the standpoint of both health protection and enforcement, the action plan provides all the European bodies concerned with guiding principles to help them fix their priorities in this area. The guidelines are based on five specific actions: coordination, reduction in demand, reduction in supply, international cooperation and information, research and assessment.

Document or Iniciative

EU Drugs Action Plan (2005-2008) of 8 July 2005 [Official Journal C 168 of 8.7.2005].

Summary

This action plan provides a consistent framework at European Union (EU) level for the adoption of enforcement and preventive measures aimed at reducing the supply of and demand for drugs. Its ultimate aim is to significantly reduce the prevalence of drug use among the population as well as to lessen the social harm and damage to health caused by the use of and trade in illicit drugs.

The action plan follows the structure and the objectives of the EU drugs strategy 2005-12, and seeks concrete results in specific priority areas.

For each objective, the Commission sets out the action(s) proposed, the corresponding timetable, the responsible authority, as well as the assessment tool or appropriate indicator. About eighty such actions are provided for.

The actions are based on five priorities:

  • coordination of anti-drugs policy at EU level;
  • demand reduction;
  • supply reduction;
  • international cooperation;
  • information and research on drugs, and evaluation of the actions undertaken.

Coordination

The action plan stresses the importance of effective coordination at Community and national levels. In particular, it provides for the adoption of national programmes conforming to the EU strategy and action plans, the appointing of a drugs coordinator within each Member State and the Commission and more involvement by civil society.

Furthermore, the action plan appoints the Horizontal Drugs Group (HDG) as the leading forum in the Council for coordination on drugs and recommends the systematic mainstreaming of drugs policy into relations and agreements with relevant countries.

Demand reduction

The Member States and the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) must, in particular, extend the scope of drug demand reduction programmes, assess them and disseminate the best practices assessed.

Furthermore, Member States must improve access to prevention programmes in schools and make them more effective. They must also improve prevention methods and the detection of risk factors in certain target groups, especially young people, as well as the dissemination of these data to the professionals in order to implement early intervention programmes.

Member States should also ensure that targeted treatment, re-education and social reintegration programmes that incorporate tested psychosocial and pharmacological strategies are available and accessible and include drug addicts not reached by existing services, with particular attention being paid to specialised services for young people.

The plan also recommends developing further alternatives to imprisonment for addicts and the setting-up of prevention, treatment and reintegration services for prisoners.

As regards the health of drug users, a Commission report on the implementation of Council Recommendation 2003/488/EC concerning the prevention and reduction of health-related harm associated with drug dependence is to be submitted by 2006 at the latest. Member States must also improve access to harm reduction services and treatment, and also set up programmes preventing the propagation of the AIDS virus, hepatitis C and other blood-borne diseases. They should also endeavour to reduce the number of drug-related deaths.

Supply reduction

Reducing supply means improving training for professionals and strengthening police cooperation between Member States and, where appropriate, with Europol, Eurojust and third countries. Achieving this aim will entail:

  • implementing operational enforcement programmes (joint investigation teams, etc.) and joint intelligence projects;
  • maximum use of the operational and strategic potential of Europol by improving the regularity with which relevant information is sent to the agency and made available to the Member States;
  • strengthening controls on the EU’s external borders;
  • specific measures to deal with the cross-border trade in drugs.

The action plan also contains measures to reduce the production of heroin, cocaine, cannabis and synthetic drugs, as well as trade in them, in particular by implementing operational joint programmes, collecting intelligence on third countries involved in the manufacturing and trading of such drugs, sharing best practice and exchanging information. Measures will also be adopted to combat the diversion and smuggling of drug precursors, such as the implementation of projects like the European joint unit on precursors.

The action plan also covers activities connected with the supply of drugs, chiefly in the form of measures targeted at money laundering and the seizure and re-use of financial products connected with drugs, in particular through exchanges of information and best practices. Similarly, certain measures are aimed at highlighting the links between drug trafficking and the financing of terrorism, as well as at collecting data on the use of information technologies in drug-related criminal activities.

International cooperation

The action plan aims to improve the coordination, effectiveness and visibility of EU action in international organisations and forums such as the United Nations, in particular by presenting joint positions and promoting its drugs strategy.

In addition, particular efforts must be made to improve assistance given to applicant countries, potential applicant countries or countries affected by the neighbourhood policy, in order to implement the acquis in this area or take the necessary action. Such efforts include technical assistance and the signing of appropriate agreements with the countries concerned.

Furthermore, whilst continuing its political commitment and cooperation with regard to third countries concerned by the drugs problem, the EU must intensify its efforts at enforcement, focussing in particular on producer countries and the regions in which the drug trafficking routes are located.

Information, research and evaluation

In order to gain a clearer picture and understanding of the drugs problem, the action plan calls for the supply of reliable information, in particular through the introduction of five key epidemiological indicators. Emerging trends must also be identified, as well as user habits and characteristics of the drugs markets, by means of surveys, Community guidelines and tools for detecting and following up such trends.

The action plan encourages research into the factors underlying dependency and into questions on the effects of certain drugs and effective health measures. The action plan also encourages the setting-up of excellence networks in the field of drug research.

Follow-up of the action plan

Assessment tools and indicators for each action, which were designed with the assistance of the EMCDDA and Europol, will help the Commission to monitor the implementation of the action plan.

The Commission will carry out an impact study in 2008, in order to propose a second action plan for 2009-12. It will conduct a final assessment of the strategy and the action plans in 2012.

Background

The EU anti-drugs strategy, adopted by the Brussels European Council in December 2004, includes a series of measures designed to curb demand for drugs, improve treatments for drug addicts and reduce the availability of illegal drugs. It commits Member States to strengthening the cohesion of their drug enforcement policies. It establishes two consecutive plans between 2005 and 2012. This strategy is an essential element of the Hague Programme, a multiannual programme aimed at strengthening freedom, security and justice in the EU.

Related Acts

 of 20 December 2008 [Official Journal C 326 of 20.12.2008].

The EU drugs action plan for the period 2009-12 follows on from that for the period 2005-08. Taking into consideration the lessons learned over the first four-year period, the plan builds on the established framework to reduce the demand for and supply of drugs.

Commission staff working document – Accompanying document to the communication from the Commission to the Council and the European Parliament on an EU Drugs Action Plan (2009-2012) – Report of the final evaluation of the EU drugs action plan (2005-2008) [SEC(2008) 2456 – Not published in the Official Journal].

Communication from the Commission of 10 December 2007 on the 2007 Progress Review of the implementation of the EU Action Plan on Drugs (2005-2008) [COM(2007) 781 final – Not published in the Official Journal].
The Commission identifies some positive aspects, in particular the convergence of national policies and further progress towards completion of the strategy’s objectives. However, it points to a lack of information on the impact the actions have in the framework of the anti-drug strategy. It therefore advocates the establishment of a methodology for evaluating the impact of these actions, adding that efforts should be pursued on the exchange of national information and alignment of the action plan indicators. It indicates its intention to undertake a final evaluation of the 2005-08 action plan on drugs and to draft a proposal on the 2009-12 action plan.

Commission staff working document of 21 December 2006 – 2006 Progress Review on the implementation of the EU Drugs Action Plan (2005-2008) [SEC(2006) 1803 – Not published in the Official Journal].


Another Normative about The EU drugs action plan

Topics

These categories group together and put in context the legislative and non-legislative initiatives which deal with the same topic

Justice freedom and security > Combating drugs

The EU drugs action plan (2009-12)

Document or Iniciative

EU Drugs Action Plan for 2009-2012 of 20 December 2008 [Official Journal C 326 of 20.12.2008].

Summary

Following on from the EU drugs action plan 2005-08, the current action plan builds on the measures established to coordinate drugs policy in Member States. These two action plans implement the EU drugs strategy for 2005-12, which was adopted by the European Council in December 2004. The overall aim of these instruments is to reduce the demand for and supply of drugs, as well as the social and health damage the use of and trade in drugs causes.

Based on the existing framework, the action plan for the period 2009-12 provides for specific actions under five priority areas:

Improve coordination

In order to develop and implement drugs policy more effectively, coordination and cooperation at the European and national levels must be strengthened. The Council’s Horizontal Drugs Group (HDG) should pro-actively coordinate EU drug policy. At the same time, the Council together with the Commission must ensure that the internal and external drugs policies are coherent. To move forward with specific and urgent issues, the national drugs coordinators should be convened on a regular basis.

At the national level, a balanced and integrated approach should be taken in forming drugs policy, with the civil society enabled to participate in informing thereof. The Commission should consult the Civil Society Forum on Drugs at least once a year and invite civil society (via “The European Alliance on Drugs” initiative) to contribute to the fight against drugs.

Reduce demand

The measures that reduce drug use and the related health and social consequences must be made more effective. In particular, the accessibility to as well as availability and quality of services that prevent, treat and reduce harm should be improved. Successful prevention programmes and interventions should be made available for a variety of target groups. Due regard should be given to the specific needs of drug users, especially in terms of age, gender, cultural background, etc. Targeted measures should also be put in place to prevent high risk behaviour of drug users.

The offer of drug treatments that consist of both psychological and pharmacological measures should be improved and new rehabilitation and re-integration programmes developed. The availability and effectiveness of demand reduction interventions should be surveyed by Member States. They should also agree on common minimum quality standards and benchmarks for these services.

Member States should make more use of sanctions other than prison to punish drug-offenders. At the same time, services for drug users in prison should be developed, with particular emphasis placed on health care as well as follow-up care upon release. Member States should also take steps to guarantee access to appropriate services to prevent the propagation of HIV/AIDS, hepatitis C and other blood-borne infectious diseases, as well as to reduce the number of deaths caused by drugs.

Reduce supply

Law enforcement cooperation at European level must be improved in order to fight drug production and trafficking effectively. To that end, multidisciplinary operations involving Europol, Eurojust, as well as police, customs and border control services should be used to a greater extent through bilateral and multilateral cooperation initiatives, namely joint investigation teams (JIT) and joint customs operations (JCO). Furthermore, judicial cooperation among Member States should be improved, especially by encouraging the full application of EU instruments for mutual recognition and assistance.

With a view to responding to emerging threats in a rapid and effective manner at the operational level, regional security platforms, such as the Maritime Analysis and Operations Centre – Narcotics (MAOC-N) and the Baltic Sea Task Force (BSTF) should be set up. At the same time, manufacturing and supplying of synthetic drugs as well as the trafficking of drug precursors must be diminished. This requires enhanced border control management and international operational cooperation.

Improve international cooperation

The effectiveness of cooperation with third countries and international organisations must be improved. The EU drugs policy must be incorporated into the general development and security agenda. Alternative development projects and programmes should be supported through increased financial aid. Projects aimed at producer countries and countries along trafficking routes should be stepped up to reduce the demand for and supply of drugs. Similarly, regional and intraregional cooperation funded by Member States and EC programmes should be enhanced with third countries. Monitoring and assessment tools must also be developed to evaluate EU assistance.

The European integrated and balanced approach to the drugs problem should be promoted, in particular through the United Nations Commission on Narcotic Drugs (CND). Furthermore, EU drug-related activities should be coordinated with a wide range of international programmes.

Finally, the candidate and stabilisation and association process countries should be given technical and other assistance so that they may become familiar with the EU acquis and take the necessary actions concerning drug-related issues. Such dialogue should also be developed with the European Neighbourhood Policy countries.

Improve understanding of the drugs phenomenon

Understanding of the drugs phenomenon in the EU must be increased, not least to raise awareness among citizens, but also to expand the knowledge base for public policy. This should be achieved through the promotion of research and of exchanges of drug-related data.

It is essential that monitoring instruments, such as the five key epidemiological indicators of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), be further developed to assess the drug situation in Europe. Member States must regularly evaluate their drug policies and amend them accordingly.

The current action plan shall be reviewed annually. In addition, the implementation of the EU drugs strategy for 2005-12 and of this action plan shall be assessed in 2012, with a view to considering any follow-up actions.

Approximation of the laws of the Member States

Approximation of the laws of the Member States

Outline of the Community (European Union) legislation about Approximation of the laws of the Member States

Topics

These categories group together and put in context the legislative and non-legislative initiatives which deal with the same topic.

Justice freedom and security > Combating drugs

Approximation of the laws of the Member States (2)

To more effectively coordinate and improve the European Union’s strategy for combating illicit drug-trafficking and in particular to improve cooperation in criminal matters in this area.

2) Document or Iniciative

Council Resolution 97/C 10/02 of 20 December 1996 on sentencing for serious drug-trafficking [Official Journal C 10 of 11.1.1997].

3) Summary

Member States will ensure that their national laws provide for the possibility of custodial sentences for serious illicit trafficking in drugs that are within the range of the most severe custodial penalties imposed by their respective criminal law for crimes of comparable gravity.

The factors which might be taken into account regarding custodial penalties that might be applicable in relation to serious drug-trafficking could include, among other factors:

  • the extent of the trafficking,
  • the extent to which the person concerned has profited from the illicit traffic,
  • the involvement in the offence of an organised criminal group to which the offender belongs,
  • the extent to which the offender has control of the drug-trafficking organisation,
  • the victimisation or use of minors.

4) Implementing Measures

5) Follow-Up Work


Another Normative about Approximation of the laws of the Member States

Topics

These categories group together and put in context the legislative and non-legislative initiatives which deal with the same topic

Justice freedom and security > Combating drugs

Approximation of the laws of the Member States (1)

Document or Iniciative

Joint Action 96/750/JHA adopted by the Council on the basis of Article K.3 of the Treaty on European Union concerning the approximation of the laws and practices of the Member States of the European Union to combat drug addiction and to prevent and combat illegal drug trafficking [Official Journal L 342 of 31 12 1996].

Summary

The Member States are to undertake to cooperate fully in the fight against drug addiction and endeavour to approximate their laws to make them mutually compatible to the extent necessary to prevent and combat illegal drug trafficking in the Union.

The Member States are to endeavour to make the practices of their police, customs services and judicial authorities more compatible with each other, thus making for closer European cooperation to prevent and combat illegal drug trafficking the Union.

The Member States are to undertake to combat illicit movements of narcotic drugs and psychotropic substances within the Community, including “drug tourism”.

The Member States are to ensure that under their legal systems the penalties imposed for serious drug trafficking are among the most severe available for crimes of comparable gravity.

The Member States are to endeavour to draft convergent legislation to the extent necessary to make up legal ground or fill legal vacuums as regards synthetic drugs. In particular, they will promote the establishment of a rapid information system to enable such drugs to be identified as substances liable to be prohibited as soon as they appear anywhere in a Member State.

The Member States are to undertake to adopt the necessary measures to effect a tangible increase in operational cooperation between police, customs services and judicial authorities in combating drug addiction and preventing and combating illegal drug trafficking.

The Member States are to ensure that their obligations under the United Nations Conventions on narcotic drugs and psychotropic substances of 1961, 1971 and 1988 are applied strictly and effectively.

The Member States are to undertake to take the most appropriate steps to combat the illicit cultivation of plants containing active ingredients with narcotic properties.

The Member States are to undertake, subject to their constitutional principles and the basic concepts of their legal systems, to make it an offence publicly and intentionally to incite or induce others, by any means, to commit offences of illicit use or production of narcotic drugs. They will be especially vigilant as regards the use made of on-line data services, in particular the Internet.

The Member States may maintain or introduce into their territory any additional measure they deem appropriate to fight drug addiction.

Related Acts

Note from the Council of 22 November 2004 on the EUfor the period 2005-2012 [15074/04 – Not published in the Official Journal].

of 25 October 2004 laying down minimum provisions on the constituent elements of criminal acts and penalties in the field of illicit drug trafficking.

of 20 December 1996 on sentencing for serious drug-trafficking [Official Journal C 10 of 11.1.1997].

Police/customs agreements in the fight against drugs

Police/customs agreements in the fight against drugs

Outline of the Community (European Union) legislation about Police/customs agreements in the fight against drugs

Topics

These categories group together and put in context the legislative and non-legislative initiatives which deal with the same topic.

Customs

Police/customs agreements in the fight against drugs

Document or Iniciative

Council Resolution of 29 November 1996 on the drawing up of police/customs agreements in the fight against drugs [Official Journal C 375 of 12.12.1996].

Summary

To emphasise the need for a close working relationship between police forces and customs services, define their respective roles in the context of drug law enforcement activities and enable them to work together more effectively, the Council urges Member States to establish national legislative, regulatory and administrative provisions.

Agreements or other arrangements between police and customs services may contain, but need not be limited to, provisions in respect of the following matters:

  • the precise delineation of, and respect for, the competences of each of the two services, including responsibility for drug seizure and related evidence, questioning and detention of suspects, investigation and, where applicable, prosecution;
  • exchange and sharing of relevant intelligence information;
  • exchange of descriptions of drug traffickers’ modus operandi;
  • exchange of information on the application of risk analysis techniques;
  • exchange of liaison officers at headquarters level of the two services with a view to building up mutual trust and confidence;
  • putting in place close liaison arrangements at local level;
  • joint agreed press statements;
  • joint police-customs task forces, where appropriate, for intelligence and/or investigation purposes;
  • agreed police-customs procedures for operational matters involving both agencies and, where appropriate:
  • joint police-customs mobile patrol squads;
  • joint police-customs training programmes;
  • sharing of equipment by police and customs.

The agreements or arrangements referred to in the resolution may also be extended to include law enforcement agencies other than police and customs.

Related Acts

Council Decision 2005/681/JHA of 20 September 2005 establishing the European Police College (CEPOL) and repealing Decision 2000/820/JHA [Official Journal L 256 of 1.10.2005].

The European Police College (CEPOL) is a cooperation network linking national training institutes for senior police officers. Its objective is to develop a common approach to the issues of crime prevention and the fight against crime through training, the setting-up of harmonised programmes and dissemination of best practice.

The EU drugs action plan (2005-2008) [Official Journal C168 of 8.7.2005].

The action plan sets out guiding principles to help Member States establish their priorities for combating drugs. The guidelines are based on five specific areas of action: coordination, reduction in demand, reduction in supply, international cooperation and information, and research and assessment.

Note from the Council of 22 November 2004 on the EU Drugs Strategy for the period 2005-2012 [15074/04 – not published in the Official Journal].

The main aim of the EU Drugs Strategy is to attain a high level of health protection and well-being by complementing the Member States’ action in preventing and reducing drug use and drug dependence.

Council Resolution of 17 December 2003 on training for drug law enforcement officers [Official Journal C 38 of 12.2.2004].

This resolution highlights the need to ensure greater alignment of training tools and methods for the training of drug law enforcement officers in the Member States. The Council urges the Member States to adapt their training to the constant changes in action on drugs and to exchange know-how and best practices.